Zofran Odt
Pruritus, Hyperemesis Gravidarum, Nausea + 8 more
Treatment
4 Active Studies for Zofran Odt
Treatment for
Pruritus
What is Zofran Odt
Ondansetron
The Generic name of this drug
Treatment Summary
Ondansetron is a medicine used to prevent nausea and vomiting caused by chemotherapy treatments. It works by blocking the action of serotonin, a brain chemical that can cause nausea and vomiting. It was developed in the 1980s by GlaxoSmithKline and approved by the US FDA in 1991. It is available in tablet, orally disintegrating tablet, and injection forms and can be taken as a generic drug. Recently, it has been formulated into orally soluble films that make it easy to take during vomiting.
Zofran
is the brand name
Zofran Odt Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Zofran
Ondansetron
1991
583
Effectiveness
How Zofran Odt Affects Patients
Ondansetron is a medicine that blocks serotonin receptors in the body, stopping the vomiting reflex and reducing nausea and vomiting. It is a relatively safe drug, but can cause a slight increase in the QTc interval, a measure of electrical activity in the heart. At the highest tested dose of 32mg, this increase can last up to 4 hours but is not expected to be significant at the recommended 8mg dose. Studies have also shown that ondansetron does not affect esophageal, gastric, or small intestinal motility, or lower esophageal sphincter pressure. However, it
How Zofran Odt works in the body
Ondansetron works to block a vomiting reflex caused by the release of serotonin. This reflex is triggered by chemotherapy or radiation treatments, and can be blocked by Ondansetron's action on serotonin receptors. Ondansetron also works on serotonin receptors located in the central nervous system and peripheral nervous system to prevent emesis. It's impact on opiate-induced emesis is still being studied.
When to interrupt dosage
The suggested measure of Zofran Odt is contingent upon the mentioned circumstance, for example, Uremia, radiation therapy induced nausea and vomiting and Pharmacotherapy. The amount likewise fluctuates as per the implementation approach featured in the table beneath.
Condition
Dosage
Administration
Pharmacotherapy
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Film, soluble, Film, soluble - Oral, Solution - Intramuscular; Intravenous, Solution - Intravenous, Liquid, Liquid - Intravenous, Film - Oral, Film, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular
Nausea
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Film, soluble, Film, soluble - Oral, Solution - Intramuscular; Intravenous, Solution - Intravenous, Liquid, Liquid - Intravenous, Film - Oral, Film, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular
Uremia
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Film, soluble, Film, soluble - Oral, Solution - Intramuscular; Intravenous, Solution - Intravenous, Liquid, Liquid - Intravenous, Film - Oral, Film, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular
Pharmacotherapy
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Film, soluble, Film, soluble - Oral, Solution - Intramuscular; Intravenous, Solution - Intravenous, Liquid, Liquid - Intravenous, Film - Oral, Film, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular
Malignant Neoplasms
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Film, soluble, Film, soluble - Oral, Solution - Intramuscular; Intravenous, Solution - Intravenous, Liquid, Liquid - Intravenous, Film - Oral, Film, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular
Pruritus
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Film, soluble, Film, soluble - Oral, Solution - Intramuscular; Intravenous, Solution - Intravenous, Liquid, Liquid - Intravenous, Film - Oral, Film, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular
Hyperemesis Gravidarum
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Film, soluble, Film, soluble - Oral, Solution - Intramuscular; Intravenous, Solution - Intravenous, Liquid, Liquid - Intravenous, Film - Oral, Film, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular
Nausea
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Film, soluble, Film, soluble - Oral, Solution - Intramuscular; Intravenous, Solution - Intravenous, Liquid, Liquid - Intravenous, Film - Oral, Film, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular
radiation therapy induced nausea and vomiting
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Film, soluble, Film, soluble - Oral, Solution - Intramuscular; Intravenous, Solution - Intravenous, Liquid, Liquid - Intravenous, Film - Oral, Film, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular
Nausea
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Film, soluble, Film, soluble - Oral, Solution - Intramuscular; Intravenous, Solution - Intravenous, Liquid, Liquid - Intravenous, Film - Oral, Film, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular
Malignant Neoplasms
3.2 mg/mL, , 2.0 mg/mL, 8.0 mg, 4.0 mg, 24.0 mg, 4.0 mg/mL, 0.4 mg, 16.0 mg, 2.0 mg, 8.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, film coated - Oral, Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, coated, Tablet, coated - Oral, Tablet, orally disintegrating - Oral, Film, soluble, Film, soluble - Oral, Solution - Intramuscular; Intravenous, Solution - Intravenous, Liquid, Liquid - Intravenous, Film - Oral, Film, Injection - Intravenous, Sublingual, Troche, Troche - Sublingual, Intramuscular, Injection, solution - Intramuscular
Warnings
Zofran Odt Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Zofran Odt.
Common Zofran Odt Drug Interactions
Drug Name
Risk Level
Description
Amitriptyline
Major
The metabolism of Amitriptyline can be decreased when combined with Ondansetron.
Amoxapine
Major
The metabolism of Amoxapine can be decreased when combined with Ondansetron.
Anagrelide
Major
The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Anagrelide.
Apomorphine
Major
The risk or severity of adverse effects can be increased when Ondansetron is combined with Apomorphine.
Arsenic trioxide
Major
The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Arsenic trioxide.
Zofran Odt Toxicity & Overdose Risk
Taking too much ondansetron can cause some unusual side effects, such as temporary blindness, low blood pressure, muscle and nerve problems, drowsiness, and seizures. It is not recommended to take ondansetron during pregnancy, and nursing mothers should avoid taking this drug as it can be excreted in the milk of rats. There is not enough information to provide dosage recommendations for children under 3 years old.
Zofran Odt Novel Uses: Which Conditions Have a Clinical Trial Featuring Zofran Odt?
Currently, two active trials are investigating the potential of Zofran Odt to provide relief from Nausea, Uremia and Radiation therapy induced Nausea and Vomiting.
Condition
Clinical Trials
Trial Phases
Hyperemesis Gravidarum
0 Actively Recruiting
Nausea
0 Actively Recruiting
radiation therapy induced nausea and vomiting
0 Actively Recruiting
Malignant Neoplasms
0 Actively Recruiting
Nausea
3 Actively Recruiting
Phase 2, Not Applicable, Phase 3
Nausea
0 Actively Recruiting
Pruritus
0 Actively Recruiting
Pharmacotherapy
0 Actively Recruiting
Uremia
0 Actively Recruiting
Pharmacotherapy
1 Actively Recruiting
Not Applicable
Malignant Neoplasms
0 Actively Recruiting
Zofran Odt Reviews: What are patients saying about Zofran Odt?
5
Patient Review
5/26/2013
Zofran Odt for Nausea and Vomiting
5
Patient Review
3/8/2015
Zofran Odt for Vomiting in Children due to Acute Gastroenteritis
5
Patient Review
5/17/2015
Zofran Odt for Nausea and Vomiting
5
Patient Review
2/25/2014
Zofran Odt for Nausea and Vomiting
5
Patient Review
6/7/2012
Zofran Odt for Nausea and Vomiting
5
Patient Review
11/27/2011
Zofran Odt for Nausea and Vomiting
4.7
Patient Review
6/19/2013
Zofran Odt for Prevent Nausea and Vomiting from Cancer Chemotherapy
4.7
Patient Review
6/19/2013
Zofran Odt for Nausea and Vomiting caused by Cancer Drugs
4.7
Patient Review
4/10/2010
Zofran Odt for Nausea and Vomiting
4.3
Patient Review
12/7/2016
Zofran Odt for Nausea and Vomiting
4
Patient Review
5/1/2013
Zofran Odt for Nausea and Vomiting
3.3
Patient Review
11/29/2016
Zofran Odt for Nausea and Vomiting
2.7
Patient Review
12/13/2018
Zofran Odt for Nausea and Vomiting
2.3
Patient Review
3/22/2018
Zofran Odt for Nausea and Vomiting
2
Patient Review
4/6/2011
Zofran Odt for Prevent Nausea and Vomiting After Surgery
1.7
Patient Review
10/17/2009
Zofran Odt for Nausea and Vomiting
1
Patient Review
12/26/2020
Zofran Odt for Prevent Nausea and Vomiting After Surgery
Patient Q&A Section about zofran odt
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What does ODT mean in Zofran ODT?
"Ondansetron disintegrates in your mouth, and it's used to prevent nausea and vomiting that may be caused by certain medical treatments."
Answered by AI
What is the difference between Zofran and Zofran ODT?
"ZOFRAN ODT Tablets are administered orally and dissolve on the tongue, without the need for water. Each 5 ml of ZOFRAN Oral Solution contains 4 mg of ondansetron."
Answered by AI
What is Zofran ODT prescribed for?
"This medication works by blocking a natural substance (serotonin) that causes vomiting.
This medication is used to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. It is also used to prevent and treat nausea and vomiting after surgery.
This medication works by blocking a natural substance (serotonin) that causes vomiting."
Answered by AI
How long does it take ODT Zofran to work?
"How long does it take for Zofran to start working?
Zofran should work pretty quickly for most people. Many people report feeling relief within about 30 minutes, and it reaches maximum blood concentrations in about 2 hours. The effects of Zofran can last between 8 to 12 hours."
Answered by AI